Maria Paricio, MD
Geriatric Psychiatry · South Miami, FLNPI 1104868538
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $473 of the $483 with a category attached, or 97.9%. Every reported general payment came from a single manufacturer, Grifols Biologicals LLC.
Across 3 payments — averaging $160.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Biologicals LLC$483
Across 101 payments — averaging $4939.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Grifols Biologicals LLC$317K
- Eisai Inc.$146K
- Novartis$35K
What the payments were for
- Travel & lodging$47398%
- Food & beverage$102%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols Biologicals LLC | 3 | $483 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Albutein$473
- Flebogamma DIF$473
How this compares
$483 in reported general payments places this provider in the 60th percentile of 33 geriatric psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 350 | $5,972 |
| Lorazepam | 247 | $2,736 |
| Temazepam | 183 | $2,439 |
| Olanzapine | 72 | $2,021 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 34 | $1,681 |
| Divalproex Sodium | 16 | $1,576 |
| Alprazolam | 122 | $1,538 |
| Triazolam | 21 | $1,514 |
| Clonazepam | 179 | $1,438 |
| Escitalopram Oxalate | 99 | $1,364 |
| Memantine Hcl | 33 | $1,311 |
| Fluvoxamine Maleate | 39 | $1,140 |
| Valproic Acid | 18 | $931 |
| Valproic AcidValproic Acid (As Sodium Salt) | 20 | $904 |
| Trazodone Hcl | 53 | $867 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in South Miami
- Ivan CichowiczBoca Raton$255K
- Amanda SmithTampa$10K
- Julio MachadoMiami$8K
- Luis VinuelaMelbourne$7K
- Nandita JoshiJacksonville$3K
- Ramon PinoGainesville$2K
- Willy PhiliasWest Palm Beach$1K
- Luis AllenOrlando$1K
- Barbara SrurSarasota$1K
- Edward KilleenFort Myers$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.